Cabozantinib Improves Survival in Advanced Hepatocellular Cancer
FRIDAY, July 6, 2018 — Cabozantinib results in significantly longer overall and progression-free survival than placebo among patients with advanced
Read more
FRIDAY, July 6, 2018 — Cabozantinib results in significantly longer overall and progression-free survival than placebo among patients with advanced
Read more